GLP & METABOLIC
Cagrilintide 10mg
Metabolic research peptide.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99%
purity
✓ Passed full QC panel
- Variant
- Cagrilintide 10mg · 10 mg
- Lot #
- TBD
- Labeled
- 10 mg
- Tested
- —
Full QC panel
- Purity (HPLC)
- 99%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 1415456-99-3
- Molecular Formula
- C194H312N54O59S2
- Molecular Weight
- 4409 g/mol
- Sequence
- (see COA)
- Type
- Research peptide
- PubChem
- CID 171397054 ↗
Biological targets
Interactions
- Primary target
- Amylin and calcitonin receptors
- Pathway
- AMY / CTR signaling; satiety
- Mechanism
- Long-acting amylin analog
- Research area
- Appetite and body-weight research
Physical properties
Handling & Storage
- Appearance
- White lyophilized powder
- Solubility
- Soluble in sterile water; reconstitute prior to use
- Storage
- 2-8 deg C, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
JOURNAL OF MEDICINAL CHEMISTRY
Development of Cagrilintide, a Long-Acting Amylin Analogue
2021 · PMID 34288673
Kruse T et al.
View Source ↗CARDIOLOGY IN REVIEW
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
2024 · PMID 36883831
D'Ascanio AM et al.
View Source ↗LANCET (LONDON, ENGLAND)
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 · PMID 37364590
Frias JP et al.
View Source ↗LANCET (LONDON, ENGLAND)
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2021 · PMID 34798060
Lau DCW et al.
View Source ↗EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Amylin analogs for the treatment of obesity without diabetes: present and future
2024 · PMID 39317404
Panou T et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.